Rhenovia
Maison du Technopole - B.P. 2118
40 Rue Marc Seguin
Mulhouse
Cedex
F-68060
France
Tel: 33-3-89327684
Fax: 33-3-89327631
Website: http://www.rhenovia.com/
Email: info@rhenovia.com
12 articles about Rhenovia
-
Rhenovia Secures Series B Funding
2/12/2014
-
Rhenovia Announces the Development of the First Simulator for the Biological Mechanisms of Epilepsy
10/28/2013
-
Rhenovia Pharma Recognized as the World Leader in Biosimulation of the Central Nervous System
2/4/2013
-
Rhenovia Files Two Patent Applications for RHEpatch™, an Electronic Transdermal Patch for Controlled Drug Delivery
11/28/2012
-
Rhenovia Files Patents for New Treatment of Huntington's Disease Based on Its Innovative Biosimulation Platform
5/31/2012
-
Rhenovia Launches Drug Discovery Programs in Rare, Orphan and Neglected Neurodegenerative Diseases
3/19/2012
-
Rhenovia Opens First US Office
1/25/2012
-
Rhenovia's RHETOX Project is Selected by France's Ministries of Defense and Economy, for Financing of EUR 1.15 Million
9/1/2011
-
Rhenovia Enters Into a Strategic Alliance with Portmann Instruments for Marketing its Biosimulation Services in Switzerland
5/25/2011
-
Rhenovia Signs an R&D Contract with Sodiaal-Candia for Studying the Nutritional and Therapeutic Value of Milk and its Derivatives
4/26/2011
-
Rhenovia Signs Two-Year EUR 500,000 Partnership With AFM to Support its Simulation Technology for Diseases of the Nervous System
12/9/2010
-
Rhenovia Obtains Significant Research Contract With The US National Institutes of Health (NIH)
7/29/2009